These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 19578174)

  • 1. Are complications of implantable defibrillators under-estimated and benefits over-estimated?
    Brignole M
    Europace; 2009 Sep; 11(9):1129-33. PubMed ID: 19578174
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
    Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
    Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillators confer survival benefit in patients with chronic obstructive pulmonary disease.
    Razak E; Kamireddy S; Saba S
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1125-30. PubMed ID: 20487355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary prevention of sudden cardiac death].
    Reek S; Geller JC; Klein HU
    Dtsch Med Wochenschr; 2001 Apr; 126(15):435-8. PubMed ID: 11347006
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary prevention of sudden cardiac death. do we need to implant a defibrillator in all the patients with low ejection fraction?
    Disertori M; El-Sherif N
    Ital Heart J; 2004 Sep; 5(9):643-7. PubMed ID: 15568590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of patients with sustained ventricular arrhythmia: anti-arrhythmia agents or defibrillator?].
    Cappato R; Kuck KH
    Cardiologia; 1996 Feb; 41(2):95-105. PubMed ID: 8674097
    [No Abstract]   [Full Text] [Related]  

  • 7. The implantable defibrillator. From concept to clinical reality.
    Jordaens L
    Adv Cardiol; 1996; 38():1-168. PubMed ID: 8955754
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary].
    Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C
    Rev Esp Cardiol; 2006 Dec; 59(12):1328. PubMed ID: 17194428
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction.
    Valk S; Jordaens L
    Europace; 2009 Apr; 11(4):407-8. PubMed ID: 19279027
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lethal arrhythmia associated with heart failure].
    Shiga T; Hagiwara N; Kasanuki H
    Nihon Rinsho; 2007 May; 65 Suppl 5():364-8. PubMed ID: 17571407
    [No Abstract]   [Full Text] [Related]  

  • 12. [Automatic implantable defibrillators: long-term results].
    Leenhardt A; Thomas O; Bel A; Bizot J; Coumel P; Slama R
    Arch Mal Coeur Vaiss; 1994 Nov; 87(11 Suppl):1617-22. PubMed ID: 7771909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICD therapy: what have we learned from the clinical trials?
    Arya A; Haghjoo M; Sadr-Ameli MA
    Heart Lung Circ; 2006 Feb; 15(1):3-11. PubMed ID: 16473784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
    Naccarella F; Croci F
    G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent trends in anti-arrhythmia therapy].
    Ogawa S
    Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):439-41. PubMed ID: 7751785
    [No Abstract]   [Full Text] [Related]  

  • 16. The frustrating search for arrhythmia risk stratifiers in heart failure due to nonischemic cardiomyopathy: does T-wave alternans testing help?
    Verrier RL; Kumar K; Josephson ME
    J Am Coll Cardiol; 2007 Nov; 50(19):1905-6. PubMed ID: 17980259
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation.
    Mehta D; Mori N; Goldbarg SH; Lubitz S; Wisnivesky JP; Teirstein A
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):43-8. PubMed ID: 21193539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillators.
    DiMarco JP
    N Engl J Med; 2003 Nov; 349(19):1836-47. PubMed ID: 14602883
    [No Abstract]   [Full Text] [Related]  

  • 19. Near fatal arrhythmia induction by an implantable cardioverter defibrillator.
    Wollmann CG; Göttker U; Böcker D; Gradaus R
    J Cardiovasc Electrophysiol; 2006 Sep; 17(9):1026-8. PubMed ID: 16764706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the patient with an implantable cardioverter-defibrillator in the third millennium.
    Saksena S; Madan N
    Circulation; 2002 Nov; 106(21):2642-6. PubMed ID: 12438286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.